Albemarle [ALB] vs Axalta Coating [AXTA] Detailed Stock Comparison
Albemarle
NYSE
Loading...
Axalta Coating
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Albemarle wins in 5 metrics, Axalta Coating wins in 14 metrics, with 0 ties. Axalta Coating appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Albemarle | Axalta Coating | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.52 | 15.23 | Axalta Coating |
| Price-to-Book Ratio | 1.26 | 2.97 | Albemarle |
| Debt-to-Equity Ratio | 35.76 | 147.77 | Albemarle |
| PEG Ratio | 45.51 | -7.77 | Axalta Coating |
| EV/EBITDA | 75.63 | 9.31 | Axalta Coating |
| Profit Margin (TTM) | -22.39% | 8.58% | Axalta Coating |
| Operating Margin (TTM) | 1.90% | 15.56% | Axalta Coating |
| EBITDA Margin (TTM) | 1.90% | 15.56% | Axalta Coating |
| Return on Equity | -9.99% | 21.70% | Axalta Coating |
| Return on Assets (TTM) | -1.51% | 6.50% | Axalta Coating |
| Free Cash Flow (TTM) | $-983.72M | $436.00M | Axalta Coating |
| 1-Year Return | 3.55% | -13.66% | Albemarle |
| Price-to-Sales Ratio (TTM) | 1.93 | 1.29 | Axalta Coating |
| Enterprise Value | $14.49B | $9.44B | Albemarle |
| EV/Revenue Ratio | 2.85 | 1.82 | Axalta Coating |
| Gross Profit Margin (TTM) | 14.51% | 35.02% | Axalta Coating |
| Revenue per Share (TTM) | $43 | $24 | Albemarle |
| Earnings per Share (Diluted) | $-11.12 | $2.04 | Axalta Coating |
| Beta (Stock Volatility) | 1.63 | 1.27 | Axalta Coating |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Albemarle vs Axalta Coating Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Albemarle | 0.93% | 8.89% | 17.38% | 36.26% | -1.66% | -3.57% |
| Axalta Coating | 3.41% | 0.49% | 3.32% | -1.66% | -14.60% | -8.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Albemarle | 3.55% | -69.56% | -8.41% | 75.58% | 99.35% | 357.12% |
| Axalta Coating | -13.66% | 22.93% | 26.68% | 8.50% | 39.99% | 39.99% |
Performance & Financial Health Analysis: Albemarle vs Axalta Coating
| Metric | ALB | AXTA |
|---|---|---|
| Market Information | ||
| Market Cap | $9.85B | $6.73B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 5,303,950 | 2,981,886 |
| 90 Day Avg. Volume | 4,228,367 | 3,146,015 |
| Last Close | $82.19 | $31.82 |
| 52 Week Range | $49.43 - $113.91 | $27.58 - $41.65 |
| % from 52W High | -27.85% | -23.61% |
| All-Time High | $334.55 (Nov 07, 2022) | $41.65 (Nov 25, 2024) |
| % from All-Time High | -75.43% | -23.60% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | -0.03% |
| Quarterly Earnings Growth | 15.89% | -0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.22% | 0.09% |
| Operating Margin (TTM) | 0.02% | 0.16% |
| Return on Equity (TTM) | -0.10% | 0.22% |
| Debt to Equity (MRQ) | 35.76 | 147.77 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $66.24 | $10.46 |
| Cash per Share (MRQ) | $12.91 | $2.89 |
| Operating Cash Flow (TTM) | $1.15B | $596.00M |
| Levered Free Cash Flow (TTM) | $-349,651,872 | $384.25M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Albemarle vs Axalta Coating
| Metric | ALB | AXTA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.52 | 15.23 |
| Forward P/E | 45.51 | 12.84 |
| PEG Ratio | 45.51 | -7.77 |
| Price to Sales (TTM) | 1.93 | 1.29 |
| Price to Book (MRQ) | 1.26 | 2.97 |
| Market Capitalization | ||
| Market Capitalization | $9.85B | $6.73B |
| Enterprise Value | $14.49B | $9.44B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.85 | 1.82 |
| Enterprise to EBITDA | 75.63 | 9.31 |
| Risk & Other Metrics | ||
| Beta | 1.63 | 1.27 |
| Book Value per Share (MRQ) | $66.24 | $10.46 |
Financial Statements Comparison: Albemarle vs Axalta Coating
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALB | AXTA |
|---|---|---|
| Revenue/Sales | $1.08B | $1.26B |
| Cost of Goods Sold | $920.58M | $829.00M |
| Gross Profit | $156.30M | $433.00M |
| Research & Development | $14.10M | $17.00M |
| Operating Income (EBIT) | $18.70M | $176.00M |
| EBITDA | $190.70M | $246.00M |
| Pre-Tax Income | $-18.97M | $129.00M |
| Income Tax | $-3.98M | $30.00M |
| Net Income (Profit) | $49.30M | $99.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALB | AXTA |
|---|---|---|
| Cash & Equivalents | $1.52B | $575.00M |
| Total Current Assets | $4.11B | $2.82B |
| Total Current Liabilities | $1.94B | $1.33B |
| Long-Term Debt | $3.23B | $3.40B |
| Total Shareholders Equity | $10.27B | $2.12B |
| Retained Earnings | $5.43B | $1.78B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALB | AXTA |
|---|---|---|
| Operating Cash Flow | $564.30M | $156.00M |
| Capital Expenditures | N/A | $-45.00M |
| Free Cash Flow | $362.76M | $97.00M |
| Debt Repayment | $-10.81M | $-5.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALB | AXTA |
|---|---|---|
| Shares Short | 14.73M | 6.21M |
| Short Ratio | 3.89 | 2.09 |
| Short % of Float | 0.19% | 0.03% |
| Average Daily Volume (10 Day) | 5,303,950 | 2,981,886 |
| Average Daily Volume (90 Day) | 4,228,367 | 3,146,015 |
| Shares Outstanding | 117.56M | 218.06M |
| Float Shares | 117.09M | 215.56M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.99% | 1.03% |
Dividend Analysis & Yield Comparison: Albemarle vs Axalta Coating
| Metric | ALB | AXTA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |